United States · FDA National Drug Code directory
ERVEBO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-4293_186bf785-11e8-4ea8-b2e9-f5371ef117bc
- Product NDC
- 0006-4293
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20191219
- Source listing expiry
- 20271231
Source-listed ingredients
- ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN — 72000000 [PFU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4293-02) / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4293-01) · 0006-4293-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →